FDA-Drug2023-08-30Class III
Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.
Baxter Healthcare Corporation
Hazard
Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.
Sold states
Nationwide in the U.S.A.
Affected count
13,502 vials
Manufactured in
1 Baxter Pkwy, N/A, Deerfield, IL, United States
Products
Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1103-2023Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief